Role of Glucagon-Like Peptide–2 Deficiency in Neonatal Short-Bowel Syndrome Using Neonatal Piglets

Pediatric Research - United States
doi 10.1038/pr.2013.44
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Orphan Designation: Human Glucagon-Like Peptide-2 Analogue Linked to a Human Immunoglobulin Fc Fragment, Treatment of Short Bowel Syndrome

Case Medical Research
2019English

Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2020English

Long-Term Outcomes and Disease Burden of Neonatal Onset Short Bowel Syndrome

Journal of Pediatric Surgery
MedicineChild HealthSurgeryPediatricsPerinatology
2020English

Elevated Plasma Glucagon-Like Peptide 1 and 2 Concentrations in Ileum-Resected Short Bowel Patients With a Preserved Colon

Gastroenterology
HepatologyGastroenterology
2000English

Glucagon-Like Peptide-2 Protects Against TPN-induced Intestinal Hexose Malabsorption in Enterally Refed Piglets

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2006English

A Biological Function for Glucagon-Like Peptide-2

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1998English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Role of Lateral Septum Glucagon-Like Peptide 1 Receptors in Food Intake

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2016English

Neonatal Head Circumference in Newborns With Neonatal Abstinence Syndrome

Pediatrics
Child HealthPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy